Related Experiment Video
Updated: Aug 16, 2026

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
Published on: August 23, 2022
The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial
Mahmoud M Iravani1, Clement C M Leung, Mona Sadeghian
1Neurodegenerative Disease Research Centre, GKT School of Biomedical Sciences, King's College, London, SE1 1UL, UK.
Abstract:
Sustained reactive microgliosis may contribute to the progressive degeneration of nigral dopaminergic neurons in Parkinson's disease (PD), in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) exposed human and in non-human primates. However, the temporal relationship between glial cell activation and nigral cell death is relatively unexplored. Consequently, the effects of acute (24 h) and chronic (30 days) glial cell activation induced by unilateral supranigral lipopolysaccharide (LPS) administration were studied in rats. At 24 h, LPS administration caused a marked reduction in the number of tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the substantia nigra (SN) but striatal TH-ir was unaffected. By 30 days, the loss of TH-positive neurons in the LPS-treated nigra was no greater than at 24 h although a heterogeneous loss of striatal TH-ir was present. The loss of nigrostriatal neurons was of functional significance, as at 30 days, LPS-treated rats exhibited ipsiversive circling in response to (+)-amphetamine administration. At 24 h, there was a moderate increase in glial fibrillary acidic protein (GFAP)-ir astrocytes in the SN but a marked elevation of p47phox positive OX-42-ir microglia, and intense inducible nitric oxide synthase (iNOS)-ir and 3-nitrotyrosine (3-NT)-ir was present. However, by 30 days the morphology of OX-42-ir microglia returned to a resting state, the numbers were greatly reduced and no 3-NT-ir was present. At 30 days, GFAP-ir astrocytes were markedly increased in number and iNOS-ir was present in fibrillar astrocyte-like cells. This study shows that acute glial activation leading to dopaminergic neuron degeneration is an acute short-lasting response that does not itself perpetuate cell death or lead to prolonged microglial activation.
Insights
Acute glial activation causes short-lived microglial responses and dopaminergic neuron loss in Parkinson's disease models. This early response does not perpetuate cell death or prolonged microglial activation over time.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Sustained microgliosis is implicated in Parkinson's disease (PD) neurodegeneration.
- The temporal link between glial activation and nigral neuron death remains unclear.
Purpose of the Study:
- To investigate the temporal relationship between glial activation and dopaminergic neuron loss.
- To determine the effects of acute and chronic glial activation on nigral neurons.
Main Methods:
- Unilateral supranigral lipopolysaccharide (LPS) administration in rats to induce glial activation.
- Assessment of tyrosine hydroxylase-immunoreactive (TH-ir) neurons at 24 hours and 30 days.
- Immunohistochemical analysis of glial markers (GFAP, OX-42, iNOS, 3-NT).
Main Results:
- Acute LPS induced significant nigral TH-ir neuron loss within 24 hours, which did not worsen by 30 days.
- Microglial activation (OX-42, iNOS, 3-NT) was prominent at 24 hours but resolved by 30 days.
- Astrocyte activation (GFAP) increased by 30 days, with iNOS present in astrocytes.
Conclusions:
- Acute glial activation is a transient event that causes initial dopaminergic neuron degeneration.
- This acute response does not lead to sustained microglial activation or progressive cell death.
- Astrocyte activation may play a role in later stages, but microglial involvement is short-lived.
